The ovaries can release more than one egg during a single menstrual cycle, and emerging research suggests the process is less predictable than textbooks once taught. For decades, the standard model held that ovulation is a one-and-done event each cycle: a single dominant follicle matures, releases its egg around mid-cycle, and that’s it. Ultrasound studies over the past two decades have complicated that picture considerably, revealing that follicles develop in multiple waves and that the hormonal conditions for a second ovulation, while uncommon, are biologically plausible.
Follicular Waves and the New Model of Ovarian Function
The traditional understanding of ovulation goes something like this: a group of small follicles begins growing early in the cycle, one is “selected” as dominant while the rest fade, and that winner releases an egg. It’s a tidy story, and it’s not wrong exactly, but it turns out to be incomplete. Research using serial ultrasound imaging has shown that follicles don’t just develop in a single batch. In a landmark study tracking women throughout their cycles, about 68% showed two distinct waves of follicle development, while 32% showed three waves.1PubMed. A new model for ovarian follicular development during the human menstrual cycle Each wave involved multiple follicles growing to measurable size, with some producing a dominant follicle.
A review of the evidence on antral follicle development confirmed that multiple wave patterns exist in human cycles, and that a dominant follicle can be selected during anovulatory waves (waves that don’t lead to egg release) before the ovulatory wave that actually produces an egg at mid-cycle.2Human Reproduction Update. Ovarian antral folliculogenesis during the human menstrual cycle: a review This matters because it shows the ovary is more active throughout the cycle than the old once-per-cycle model suggested. The machinery for developing and selecting a mature follicle fires up repeatedly, and under the right hormonal conditions, more than one wave could potentially yield an egg.
The key gatekeeper is FSH, the hormone that drives follicle maturation. FSH rises during a specific window in each cycle, and the duration of that window determines how many follicles can develop far enough to ovulate. If the FSH window is wider or the levels are higher than usual, more than one follicle can cross the finish line.3PubMed. Follicle-stimulating hormone and advanced follicle development in the human This is the biological basis for double ovulation: not a separate ovulatory event days or weeks later, but two (or occasionally more) eggs maturing within the same hormonal surge and being released within roughly 24 hours of each other.
Double Ovulation and Fraternal Twins
When people ask whether you can ovulate twice in a month, what they often really want to know is whether two separate eggs can be fertilized. The answer is yes, and fraternal (dizygotic) twins are the proof. Every set of fraternal twins started with two eggs released in the same cycle, each fertilized by a separate sperm. This is not two ovulations separated by a week. It’s a single hormonal surge pushing two follicles to maturity at roughly the same time.
The rate of spontaneous dizygotic twinning varies across populations and increases with maternal age, which hints that the conditions promoting double ovulation are not random glitches but reflect real variation in ovarian physiology. Some women’s bodies produce FSH levels or patterns that regularly give two follicles the chance to mature. For them, releasing two eggs isn’t a fluke; it’s a tendency, sometimes one that runs in families.
The Genetic Side of Double Ovulation
If fraternal twins run in your family on the mother’s side, that’s not folklore. Large genetic studies have identified specific gene variants that increase the likelihood of releasing two eggs. A genome-wide association study found two key genetic regions tied to spontaneous dizygotic twinning: one near the FSHB gene, which encodes part of the FSH molecule itself, and another within SMAD3, a gene involved in how the ovaries respond to FSH.4PubMed Central. Identification of Common Genetic Variants Influencing Spontaneous Dizygotic Twinning and Female Fertility Women carrying the risk variant near FSHB had roughly 40% higher odds of having dizygotic twins.5American Journal of Human Genetics. Genome-wide Association Analyses Identify Multiple Loci Associated with Dizygotic Twinning
A more recent and larger meta-analysis confirmed these two loci and uncovered two additional ones: one near the GNRH1 gene on chromosome 8, which is involved in the hormonal signaling chain that triggers ovulation, and another near ZFPM1 on chromosome 16.6Human Reproduction. Genome-wide association study meta-analysis of dizygotic twinning illuminates genetic regulation of female fecundity The pattern across all of these genes is consistent: they affect either how much FSH the body produces or how sensitively the ovary responds to it. Both paths lead to the same outcome—a greater chance that more than one follicle matures fully in a given cycle.
This genetic architecture explains why the tendency toward double ovulation is heritable through the maternal line. A father who is himself a fraternal twin carries no increased risk of his partner releasing two eggs, because it’s the egg-producing body’s hormone levels and ovarian sensitivity that matter.
Why Double Ovulation Becomes More Common With Age
Women in their late 30s and early 40s have higher rates of dizygotic twinning than younger women, and the reason traces back to FSH. As the ovarian reserve of follicles declines with age, the feedback loop between the ovaries and the brain shifts. The ovaries produce less inhibin and estrogen per follicle, so the pituitary gland compensates by cranking up FSH. This is sometimes described as a kind of endogenous ovarian hyperstimulation: the body is essentially pushing harder to get follicles to develop, and in doing so, it sometimes pushes two over the threshold.7Springer. Ovarian aging and the perimenopausal transition: the paradox of endogenous ovarian hyperstimulation
This is one of the genuine paradoxes of reproductive aging: even as overall fertility declines, the probability of releasing multiple eggs per cycle actually goes up for a time. The perimenopausal transition is especially unpredictable. FSH levels become erratic rather than following the usual pattern, and cycles that appear regular on the outside can involve abnormal follicle selection underneath. For women in their 40s who assume they are “too old” for twins, this shifting hormonal landscape is worth knowing about.
Superfecundation and Superfetation
These are two separate phenomena that get mixed up often. Superfecundation means two eggs released in the same cycle are fertilized by sperm from different acts of intercourse. Since sperm can survive in the reproductive tract for up to five days, and two eggs can be released within a 24-hour window, it’s entirely possible for each egg to be fertilized by a different partner’s sperm. This is called heteropaternal superfecundation, and while it sounds exotic, it has been documented repeatedly. One analysis of a paternity-testing database found that about 2.4% of dizygotic twins whose parents were involved in paternity disputes turned out to have different fathers.8PubMed Central. Twins from different fathers: A heteropaternal superfecundation case report in Colombia That 2.4% figure comes from a very specific subpopulation—parents already in dispute—so it doesn’t reflect the general twin population, but it confirms the biological mechanism is real and not vanishingly rare.
Superfetation, on the other hand, would involve a completely new ovulation occurring after a pregnancy has already been established, with a second embryo implanting alongside the first. This is a different claim altogether, and the evidence in humans is far thinner. A critical review of superfetation across mammals noted that while it clearly occurs in certain fish species and possibly in some mammals like the European brown hare and the American mink, the evidence in humans is limited to scattered case reports that are difficult to confirm.9PubMed. The concept of superfetation: a critical review on a ‘myth’ in mammalian reproduction Once a pregnancy is established, progesterone levels rise sharply and normally suppress further ovulation. The hormonal environment of early pregnancy is essentially designed to prevent exactly this scenario. So while superfetation is not categorically impossible—biology tends to avoid absolutes—it is not a realistic concern for most people.
How Fertility Medications Force Double (or Multiple) Ovulation
If the body’s natural hormonal balance occasionally lets two follicles mature, fertility medications deliberately push the system further. The two most commonly used oral ovulation-induction drugs—clomiphene citrate and letrozole—work by tricking the brain into producing more FSH, which in turn drives more follicles to grow. The goal in many clinical settings is to mature one or two follicles, not a dozen, but multiple ovulation is a known and expected possibility with these drugs.
In women with polycystic ovary syndrome (PCOS), where the core problem is that follicles stall out before reaching maturity, these medications can restart the process. A large trial comparing letrozole and clomiphene in women with PCOS found that letrozole produced a cumulative ovulation rate of about 62% across treatment cycles, compared to about 48% for clomiphene.10PubMed Central. Letrozole versus Clomiphene for Infertility in the Polycystic Ovary Syndrome Letrozole also tended to produce single-follicle development more often (about 77% of the time versus 53% with clomiphene), which is actually seen as an advantage because it lowers the risk of twins and higher-order multiples.11PubMed Central. Efficacy of Letrozole vs Clomiphene Citrate for induction of ovulation in women with polycystic ovarian syndrome
Injectable gonadotropins (direct FSH injections) are even more powerful and carry a much higher risk of multiple ovulation. These are used in controlled ovarian stimulation for IVF, where the express purpose is to mature many eggs at once so they can be retrieved. The important thing to understand is that all of these interventions are working with the same biological mechanism that produces spontaneous double ovulation; they’re just amplifying the FSH signal far beyond what the body would normally allow.
PCOS and Anovulation, the Opposite Problem
Polycystic ovary syndrome provides an instructive contrast. In PCOS, the ovaries contain an unusually high density of small follicles—often visible as the “string of pearls” on ultrasound—but the hormonal environment prevents any of them from maturing to the point of ovulation. The underlying problem involves an excess of luteinizing hormone and insulin, which secondarily suppress FSH to levels too low for follicle selection to proceed normally.12Oxford Academic (Human Reproduction Update). Follicle dynamics and anovulation in polycystic ovary syndrome The result is that many women with PCOS ovulate infrequently or not at all, meaning they may go months without releasing a single egg.
When ovulation induction medications do work in PCOS, the response can be unpredictable because of that large pool of recruitable follicles. A woman who wasn’t ovulating at all can suddenly produce multiple mature follicles once FSH levels rise. This is why careful ultrasound monitoring is standard during fertility treatment for PCOS—the goal is to nudge the system toward one or two mature follicles, not unleash the whole reserve at once.
DuoStim and Ovulation in the Luteal Phase
One of the more surprising developments in reproductive medicine is a protocol called DuoStim, which deliberately stimulates the ovaries twice in a single menstrual cycle: once in the follicular phase (the first half) and again in the luteal phase (the second half, after the first ovulation). The fact that this works at all tells us something important about follicular biology: even in the luteal phase, when progesterone is high and the textbook says ovulation is suppressed, follicles can be coaxed to grow and mature if given exogenous hormones.13PubMed Central. DuoStim – a reproducible strategy to obtain more oocytes and competent embryos in a short time-frame aimed at fertility preservation and IVF purposes
DuoStim is primarily used for women who need to bank as many eggs or embryos as possible in a short timeframe, such as cancer patients facing fertility-threatening treatment. The eggs retrieved from the luteal-phase stimulation are viable and can produce healthy embryos. This protocol doesn’t prove that spontaneous double ovulation occurs weeks apart—the hormonal doses involved are far beyond anything the body naturally produces—but it does demonstrate that the ovary retains the potential for follicle development throughout the cycle, not just in the first half.
Can Stress Trigger an Extra Ovulation?
This is an area where the science gets thin but the implications are provocative. Research on the relationship between acute stress and ovulation has found that stress can trigger a surge of luteinizing hormone (LH), the hormone that directly causes egg release. The effect appears to depend on where a woman is in her cycle: when estrogen levels are already elevated, acute stress may be more likely to provoke an LH surge that could theoretically trigger ovulation.14PubMed Central. Acute stress may induce ovulation in women
Animal research has pushed this idea further. In rats, acute stress not only amplified the pre-ovulatory LH surge but actually moved it earlier in the cycle. Researchers suggested this mechanism could help explain rare cases where conception occurs at unexpected points in the menstrual cycle.15PubMed. Acute stress anticipates and amplifies the luteinizing hormone pre-ovulatory surge in rats: Role of noradrenergic neurons Extrapolating from rat studies to human ovulation requires caution, but the finding is consistent with the broader idea that ovulation timing is less fixed than calendar-based methods assume.
This doesn’t mean that a stressful week at work will reliably cause a second ovulation. The hormonal conditions have to be right—specifically, estrogen needs to be at a level that primes the system for an LH surge—and acute stress is different from chronic stress, which tends to suppress the reproductive axis rather than stimulate it. But the research does reinforce a broader point: ovulation is a product of dynamic hormonal interactions, not a clockwork event that always lands on day 14.
What LH Tracking Does and Doesn’t Tell You
Many people trying to conceive or avoid pregnancy use at-home ovulation predictor kits that detect the LH surge in urine. These kits are designed around the assumption that a single LH surge precedes a single ovulation event. But research on the shape of real LH surges has found that they are extremely variable from one cycle to the next and from one woman to another. Some surges have multiple peaks, and multi-peaked surges were associated with smaller follicles at the time of rupture and lower LH levels on the day of ovulation itself.16PubMed. Relationships between the luteinizing hormone surge and other characteristics of the menstrual cycle in normally ovulating women
What this means in practice is that a positive ovulation test tells you LH is rising, but it doesn’t tell you whether one follicle or two are about to release eggs, and it doesn’t tell you the exact timing of rupture. If two follicles are mature enough, they’ll both respond to the same LH surge, and both eggs will be released. The test kit gives you one positive reading for what might be a double event. For people using fertility awareness methods for contraception, this is a meaningful limitation: you can do everything right by the kit’s instructions and still be surprised by a twin pregnancy, because the kit was never designed to distinguish single from double ovulation.
Superconception in Other Mammals
Looking at other species helps put human double ovulation in perspective. In the European brown hare, superconception—conceiving a new litter while already pregnant with one—has been suspected for centuries. Researchers using high-resolution ultrasound on pregnant hares confirmed additional ovulations occurring before the existing pregnancy reached term, with fresh corpora lutea (the ovarian structures left behind after ovulation) appearing alongside the older ones from the first conception.17PubMed Central. Superconception in mammalian pregnancy can be detected and increases reproductive output per breeding season For hares, this appears to be an adaptation that increases reproductive output during a short breeding season.
In humans, the hormonal environment of pregnancy normally shuts down follicle development and ovulation entirely. Progesterone, hCG, and the sustained suppression of FSH create multiple redundant barriers to further ovulation. The handful of human superfetation cases reported in the medical literature remain controversial, and most reproductive biologists treat them as curiosities rather than evidence of a functioning pathway. The takeaway from comparative biology is not that humans should expect to ovulate while pregnant, but rather that the suppression of ovulation during pregnancy is an active hormonal process that could, in principle, fail under unusual circumstances. What’s routine in a hare remains extraordinary in a human.